Larimar Therapeutics所有資訊

Larimar Therapeutics | 8-K：重大事件

06/10 06:08 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 Flynn James E

06/03 18:36 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 Hamilton Thomas Edward

05/31 17:00 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 Truitt Joseph

05/31 17:00 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 SHERMAN JEFFREY W

05/31 17:00 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 LEFF JONATHAN S

05/31 17:00 (美東)

Larimar Therapeutics | 4：持股變動聲明-董事 THOMAS FRANK E

05/31 17:00 (美東)

Larimar Therapeutics | 8-K：重大事件

05/31 16:19 (美東)

Larimar Therapeutics | 8-K：重大事件

05/30 16:15 (美東)

Larimar Therapeutics | EFFECT：其他

05/28 06:06 (美東)

Larimar Therapeutics | CORRESP：信函

05/22 14:40 (美東)

Larimar Therapeutics | 8-K：重大事件

05/20 16:12 (美東)

Larimar Therapeutics | UPLOAD：其他

05/16 14:40 (美東)

Larimar Therapeutics | S-3：特定交易註冊聲明

05/09 16:56 (美東)

Larimar Therapeutics | 10-Q：季度報表

05/09 16:22 (美東)

Larimar Therapeutics | 8-K：Larimar Therapeutics公佈2024年第一季度運營和財務業績

05/09 07:07 (美東)

Larimar Therapeutics | ARS：年度報告

04/29 16:09 (美東)

Larimar Therapeutics | DEF 14A：股東委託書決議

04/29 16:09 (美東)

Larimar Therapeutics | PRE 14A：並購重組委托聲明

04/12 06:12 (美東)

Larimar Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Deerfield Management Company, L.P.(33.32%),James E. Flynn(33.32%)等

03/15 16:42 (美東)